Thompson J A, Shields A F, Porter B A, Olson D O, Rubin E, Kidd P, Fefer A
Department of Medicine, University of Washington School of Medicine, Seattle.
Leukemia. 1987 Apr;1(4):315-6.
Five patients with progressive hairy cell leukemia were treated with recombinant alpha 2-interferon and examined prospectively at 3-month intervals using serial bone marrow biopsies and magnetic resonance (MR) imaging. Pretreatment iliac crest marrow biopsies demonstrated hairy cell infiltration involving 30-90% of marrow cellularity. Concurrent pretreatment coronal images of the proximal femurs and pelvis using MR revealed extensive marrow involvement that varied in distribution from patchy to diffuse. At 6 months, all patients had responded to alpha 2-interferon with improvement in peripheral blood counts and decrease in lymphoid infiltration on marrow biopsy to 15-40%. Six-month follow-up MR scans demonstrated decreasing marrow leukemia infiltration and increasing marrow fat. MR bone marrow imaging appears useful in the initial diagnosis of hairy cell leukemia, for monitoring the response to treatment, and possibly for predicting relapse.
五例进行性毛细胞白血病患者接受了重组α2干扰素治疗,并每隔3个月进行前瞻性检查,采用系列骨髓活检和磁共振(MR)成像。治疗前的髂嵴骨髓活检显示毛细胞浸润累及30%至90%的骨髓细胞。同时,治疗前使用MR对近端股骨和骨盆进行的冠状位成像显示骨髓广泛受累,分布从斑片状到弥漫性不等。6个月时,所有患者对α2干扰素均有反应,外周血细胞计数改善,骨髓活检显示淋巴细胞浸润减少至15%至40%。6个月的随访MR扫描显示骨髓白血病浸润减少,骨髓脂肪增加。MR骨髓成像在毛细胞白血病的初始诊断、监测治疗反应以及可能预测复发方面似乎很有用。